Personalized blood test aims to track stomach and colon cancer spread

NCT ID NCT04929015

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is for people with gastrointestinal cancer that has spread to the lining of the abdomen. Researchers will collect tumor tissue and blood samples to create a custom blood test that looks for cancer DNA. The goal is to see if this test can help doctors monitor the cancer over time and guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

appendix carcinoma carcinoma of esophagus carcinoma of liver and intrahepatic biliary tract colorectal carcinoma digestive system neoplasm Digestive System Neoplasms gastric carcinoma hepatobiliary neoplasm hepatocellular carcinoma peritoneal carcinomatosis peritoneal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • RWJBarnabas Health - Cooperman Barnabas, Livingston

    Livingston, New Jersey, 07039, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, 08903, United States